Simbionix Acquires the ARTHRO VR® Product Line by GMV
CLEVELAND, January 25, 2012 /PRNewswire/ –
Simbionix USA Corporation, the world’s leading provider of medical education and
simulation training, is pleased to announce it has purchased the ARTHRO VR(R), a virtual
reality arthroscopic training simulator line from GMV, Spain. This purchase expands the
company’s training tools to provide clients with advanced solutions for orthopedic
surgeons. As with all Simbionix training simulators, this system is the ideal complement
to traditional training techniques, reducing instruction time and providing a complete
hands-on experience.
In the coming years, all arthroscopic procedures are expected to grow considerably, as
lifestyle choices nowadays include more sports and physical activities which tend to cause
more injuries. In addition, the general population has a longer lifespan and older
individuals are more susceptible to joint damage, further increasing the need for
arthroscopic procedures. These continuing changes in demographic lifestyle choices are not
only driving demand for arthroscopy from patients; they are leading more and more surgeons
to seek out training in arthroscopic techniques. Compared to conventional open surgery,
arthroscopic surgery performed by an experienced surgeon, holds numerous and well
established benefits including small incisions with a reduced risk of infection and less
pain.
ARTHRO VR is an advanced arthroscopic training simulator designed for the most
effective acquisition of the skills required for arthroscopic surgery. The simulator
features a line of simulated procedures, intelligently combining fiberglass limb replicas
with 3D images and haptic sensation, to allow users to learn key aspects of the
procedures. Simulated procedures are performed utilizing a realistic set of tools as used
in the OR including the arthroscopic camera, which allow the trainee to acquire a
true-to-life hands-on experience. Training modules in increasing difficulty include
healthy anatomies and various pathologies, provide trainees with the opportunity to
practice basic skills and master procedure skills. The product line offers educational
aids such as panoramic views and a set of metrics for complete objective assessment of the
learning process.
“Identified by Simbionix as a leading product line in a growing field, the ARTHRO VR
is a well suited addition to our current line of industry leading simulators and
integrates nicely with our global distribution channel,” said Gary Zamler, Simbionix CEO.
“This purchase demonstrates our ongoing commitment to advancing medical education, and
identifying high quality simulation technologies for our expanding global customer base.
Simbionix will continue to invest resources in arthroscopy, enhancing available modules
and growing the simulator lines capabilities. I would also like to express our
appreciation to the GMV Management team for the cooperative spirit and manner in which we
worked together so well over the past few months, leading to this desirable result.”
About Simbionix USA Corporation
Simbionix is the world’s leading provider of simulation, training and education
products for medical professionals and the healthcare industry. The company is committed
to delivering high quality products, advancing clinical performance and optimizing
procedural outcomes.
Visit: http://www.simbionix.com
Contact: rebecca@simbionix.com
+1-216-2292040
About GMV
GMV is a multinational technology business group trading on a worldwide scale in
industries such as Aerospace, Defense and Security, intelligent systems for
Transportation, Telecommunications and ICT for Healthcare, public administration and large
corporations. The company’s growth strategy is based on technological leadership and
continuous innovation; 10% of its turnover is plowed back into R&D and holds several
international patents.
Visit: http://www.gmv.com
Contact: mpozo@gmv.com
SOURCE Simbionix USA Corporation